ロード中...
MEK and the inhibitors: from bench to bedside
Four distinct MAP kinase signaling pathways involving 7 MEK enzymes have been identified. MEK1 and MEK2 are the prototype members of MEK family proteins. Several MEK inhibitors are in clinical trials. Trametinib is being evaluated by FDA for the treatment of metastatic melanoma with BRAF V600 mutati...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3626705/ https://ncbi.nlm.nih.gov/pubmed/23587417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-27 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|